BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35703766)

  • 1. Provider Perspectives on Factors Affecting the PrEP Care Continuum Among Black Cisgender Women in the Midwest United States: Applying the Consolidated Framework for Implementation Research.
    Johnson AK; Pyra M; Devlin S; Uvin AZ; Irby S; Blum C; Stewart E; Masinter L; Haider S; Hirschhorn LR; Ridgway JP
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S141-S148. PubMed ID: 35703766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POWER Up-Improving pre-exposure prophylaxis (PrEP) uptake among Black cisgender women in the Southern United States: Protocol for a stepped-wedge cluster randomized trial (SW-CRT).
    Ridgway JP; Devlin SA; Friedman EE; Enaholo OE; Pyra M; Hirschhorn LR; Haider S; Ducheny K; Johnson AK
    PLoS One; 2023; 18(5):e0285858. PubMed ID: 37196008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapting Provider Training and Pre-Exposure Prophylaxis Advertising to Increase Pre-Exposure Prophylaxis Awareness and Uptake Among Black Cisgender Women.
    Devlin SA; Ridgway JP; Dawdani A; Enaholo OE; Liegeon G; Kasal N; Pyra M; Hirschhorn LR; Simon J; Haider S; Ducheny K; Johnson AK
    AIDS Patient Care STDS; 2023 Dec; 37(12):574-582. PubMed ID: 38011350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "PrEP's just to secure you like insurance": a qualitative study on HIV pre-exposure prophylaxis (PrEP) adherence and retention among black cisgender women in Mississippi.
    Willie TC; Monger M; Nunn A; Kershaw T; Stockman JK; Mayer KH; Chan PA; Adimora AA; Mena LA; Knight D; Philllips KA; Baral SD
    BMC Infect Dis; 2021 Oct; 21(1):1102. PubMed ID: 34702165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preexposure Prophylaxis Implementation in a Reproductive Health Setting: Perspectives From Planned Parenthood Providers and Leaders.
    Wilbourn B; Ogburn DF; Safon CB; Galvao RW; Kershaw TS; Willie TC; Taggart T; Caldwell A; Kaplan C; Phillips N; Calabrese SK
    Health Promot Pract; 2023 Jul; 24(4):764-775. PubMed ID: 35414273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community Health Care Providers' Perspectives on Human Immunodeficiency Virus Pre-Exposure Prophylaxis Use Among Black Women in Eastern Virginia.
    Pitchford K; Shangani S; Dawson C; Masa R; Heron K
    AIDS Patient Care STDS; 2024 Mar; 38(3):123-133. PubMed ID: 38471092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where's the "Everyday Black Woman"? An intersectional qualitative analysis of Black Women's decision-making regarding HIV pre-exposure prophylaxis (PrEP) in Mississippi.
    Willie TC; Knight D; Baral SD; Chan PA; Kershaw T; Mayer KH; Stockman JK; Adimora AA; Monger M; Mena LA; Philllips KA; Nunn A
    BMC Public Health; 2022 Aug; 22(1):1604. PubMed ID: 35999528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.
    Pleuhs B; Quinn KG; Walsh JL; Petroll AE; John SA
    AIDS Patient Care STDS; 2020 Mar; 34(3):111-123. PubMed ID: 32109141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "PrEP"ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women.
    Pasipanodya EC; Stockman J; Phuntsog T; Morris S; Psaros C; Landovitz R; Amico KR; Moore DJ; Blumenthal J
    BMC Womens Health; 2021 May; 21(1):220. PubMed ID: 34034719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Implementation Strategies to Enhance HIV Pre-Exposure Prophylaxis Uptake Among Black Cisgender Women in New Orleans, Louisiana.
    Clement ME; Perry B; McKenna K; Beckford J; Davenport T; Murray E; Magee V; Bickham JN; Siren J; Smith A; Lillis R; Corneli A
    AIDS Patient Care STDS; 2024 Mar; 38(3):144-150. PubMed ID: 38471093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Black Cisgender Women's PrEP Knowledge, Attitudes, Preferences, and Experience in Chicago.
    Hirschhorn LR; Brown RN; Friedman EE; Greene GJ; Bender A; Christeller C; Bouris A; Johnson AK; Pickett J; Modali L; Ridgway JP
    J Acquir Immune Defic Syndr; 2020 Aug; 84(5):497-507. PubMed ID: 32692108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Let Me Prep You to PREP Me: Amplifying the Voices of Black Women and Their Providers to Consider PrEP as an HIV Prevention Option.
    Chandler R; Guillaume D; Wells J; Hernandez N
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation strategies to screen, refer and link women involved in the carceral system to PrEP for HIV prevention.
    Dauria E; Rodriguez C; Bauerle Bass S; Tolou-Shams M; Christopoulos K
    Int J Prison Health; 2023 May; ():. PubMed ID: 37113046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Controlled Pilot Study of Just4Us, a Counseling and Navigation Intervention to Promote Oral HIV Prophylaxis Uptake Among PrEP-Eligible Cisgender Women.
    Teitelman AM; Tieu HV; Chittamuru D; Shaw PA; Nandi V; Davis A; Lipsky RK; Darlington CK; Fiore D; Koblin BA
    AIDS Behav; 2023 Sep; 27(9):2944-2958. PubMed ID: 36869921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers and Facilitators to Long-Acting Injectable HIV Pre-Exposure Prophylaxis Implementation in Primary Care Since Its Approval in the United States.
    Keddem S; Thatipelli S; Caceres O; Roder N; Momplaisir F; Cronholm P
    J Acquir Immune Defic Syndr; 2024 Apr; 95(4):370-376. PubMed ID: 38133586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives of Black women in the United States on salon-based intervention to promote the uptake of pre-exposure prophylaxis (PrEP) for HIV.
    Johnson R; Myers D; McKellar M; Saint-Hillaire L; Randolph SD
    J Clin Nurs; 2021 Nov; 30(21-22):3281-3289. PubMed ID: 33969573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences of Black Women in the United States Along the PrEP Care Continuum: A Scoping Review.
    Knight D; Saleem HT; Stockman JK; Willie TC
    AIDS Behav; 2023 Jul; 27(7):2298-2316. PubMed ID: 36622485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women's views on communication with health care providers about pre-exposure prophylaxis (PrEP) for HIV prevention.
    Jackson GY; Darlington CK; Van Tieu H; Brawner BM; Flores DD; Bannon JA; Davis A; Frye V; Chittamuru D; Gugerty P; Koblin BA; Teitelman AM
    Cult Health Sex; 2022 May; 24(5):642-656. PubMed ID: 33535887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multilevel Factors Shaping Awareness of and Attitudes Toward Pre-exposure Prophylaxis for HIV Prevention among Criminal Justice-Involved Women.
    Dauria EF; Levine A; Hill SV; Tolou-Shams M; Christopoulos K
    Arch Sex Behav; 2021 May; 50(4):1743-1754. PubMed ID: 33236275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.